This could also explain the earlier onset and enhanced disease severity observed in homozygous MJD patients — they carry two disease-causing ATXN3 alleles and lack the protective function carried by wild-type ataxin-3. This evidence concerns the gene ATXN3 and Machado-Joseph disease.